Mike Mensinger Purchases 33,350 Shares of Beta Bionics, Inc. (NASDAQ:BBNX) Stock

Beta Bionics, Inc. (NASDAQ:BBNX) insider Mike Mensinger purchased 33,350 shares of the firm’s stock in a transaction dated Friday, January 31st. The shares were bought at an average price of $17.00 per share, with a total value of $566,950.00. Following the purchase, the insider now owns 59,019 shares in the company, valued at $1,003,323. This represents a 129.92 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Beta Bionics Trading Up 1.1 %

BBNX opened at $23.00 on Wednesday. Beta Bionics, Inc. has a twelve month low of $21.72 and a twelve month high of $24.50.

About Beta Bionics

We are a commercial-stage medical device company engaged in the design, development and commercialization of innovative solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing advanced adaptive closed-loop algorithms to simplify and improve the treatment of their disease.